Allianz Asset Management GmbH Sells 78,795 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR)

Key Points

• Allianz Asset Management GmbH sold 78,795 shares of OraSure Technologies, reducing its holdings by 9.8%, and now owns 726,895 shares valued at approximately $2.45 million.
• OraSure Technologies saw its stock price decrease by 2.4% recently, with a current market cap of $244.60 million and a 52-week trading range between $2.36 and $4.92.
• Research analysts have upgraded OraSure Technologies from a "sell" to a "hold" rating, with Evercore ISI setting a price objective of $3.00 for the stock.

Allianz Asset Management GmbH cut its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 9.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 726,895 shares of the medical instruments supplier's stock after selling 78,795 shares during the quarter. Allianz Asset Management GmbH owned about 0.94% of OraSure Technologies worth $2,450,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of OSUR. Tower Research Capital LLC TRC lifted its holdings in shares of OraSure Technologies by 202.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 5,234 shares in the last quarter. Causeway Capital Management LLC purchased a new position in OraSure Technologies during the 4th quarter worth $36,000. Raymond James Financial Inc. bought a new stake in shares of OraSure Technologies in the 4th quarter worth $37,000. Boothbay Fund Management LLC bought a new stake in shares of OraSure Technologies in the 4th quarter worth $42,000. Finally, Gotham Asset Management LLC bought a new stake in shares of OraSure Technologies in the 4th quarter worth $43,000. 93.50% of the stock is owned by institutional investors.

OraSure Technologies Trading Down 5.3%

Shares of OSUR stock traded down $0.17 during trading on Friday, hitting $3.01. The company's stock had a trading volume of 928,277 shares, compared to its average volume of 703,580. The company has a market cap of $225.15 million, a PE ratio of -7.17 and a beta of 0.27. The business has a fifty day moving average of $3.03 and a 200-day moving average of $3.23. OraSure Technologies, Inc. has a 52 week low of $2.36 and a 52 week high of $4.92.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Evercore ISI reaffirmed an "in-line" rating and issued a $3.00 target price on shares of OraSure Technologies in a report on Monday, May 19th. Wall Street Zen raised OraSure Technologies from a "sell" rating to a "hold" rating in a report on Saturday, May 17th.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.